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Engagement with care for those living with HIV is aimed at establishing a strong relationship between patients and their health
care provider and is often associated with greater adherence to therapy and treatment (Flickinger, Saha, Moore, and Beach, 2013).
Substance use behaviors are linked with lower rates of engagement with care andmedication adherence (Horvath, Carrico, Simoni,
Boyer, Amico, and Petroli, 2013). This study is a secondary data analysis using a cross-sectional design from a larger randomized
controlled trial (𝑛 = 775) that investigated the efficacy of a self-care symptom management manual for participants living with
HIV. Participants were recruited from countries of Africa and the US. This study provides evidence that substance use is linked
with lower self-reported engagement with care and adherence to therapy. Data on substance use and engagement are presented.
Clinical implications of the study address the importance of utilizing health care system and policy factors to improve engagement
with care.
1. Introduction
Engagement with care is a critical element of successful
adaptation to chronic illness, particularly in HIV disease [1].
Establishing a successful patient-provider relationship may
be linked with better outcomes for those living with HIV
including lower viral loads, fewer comorbid illnesses, and
slower progression to AIDS. Both alcohol and illicit drug
use are common among HIV-infected patients [2] and may
contribute to poorer adherence to antiretroviral therapy and
less engagement with health care providers. Substance use,
notably alcohol use, was found to predict HIV risk behavior
and sensation seeking in a sample of men and women in
South Africa [3] and contributes to lower utilization of
and adherence to antiretroviral therapy [4]. It is known
that medical providers have difficulty routinely addressing
unhealthy behaviors and substance use, and these behaviors
are not always addressed with patients in HIV treatment
settings [5]. Recently, Horvath et al. [6] found that stimulant
use was significantly correlated with missed HIV medical
appointments and that fewer stimulant-using men in the
study rated HIV medical care as a high priority.
1.1. Engagement with Care. Engagement with care is an
important element of the patient-provider relationship and
may be linked with health status outcomes, adherence to
therapy, and chronic and comorbid illness in HIV disease
[7]. A complex chronic illness such as HIV requires excellent
care, communication, and a committed partnership of patient
and provider [8, 9]. Dombrowski and colleagues [9] found
that engagement with care was the only significant factor
that was linked with both antiretroviral adherence and
viral load suppression. Bankoff and colleagues [10] noted
that positive patient-provider relationships were significantly
correlated with better physical health and functioning and
greater engagement in care. Rao et al. [11] noted that lack of
engagement in HIV care presents a major clinical challenge
in HIV care as well as a global public health challenge.
Mugavero et al. [12] examined health care system and
policy factors that influence engagement in HIV clinical care.
Their discussion included a socioecological framework that
includes salient health care system and policy factors that
influence engagement in HIV clinical care. They address
the importance of communication and “synergy between
funding and service agencies that provide HIV testing,
prevention, treatment, and supportive services” (p. S238).
Since HIV disease is a chronic and complex illness that
requires medication adherence, engagement with care, and
symptom management across the HIV trajectory, the impact
of, and the relationships among unhealthy substance use
behaviors, relationships with care providers and the presence
and severity of symptoms require exploration.Difficult symp-
toms are known to exist as a result of HIV disease and pro-
gression to AIDS, due to antiretroviral medication, and may
also be linked to comorbid unhealthy behaviors. It is known
that medical providers have difficulty routinely addressing
unhealthy behaviors and substance use, in particular, is often
not addressed with patients in HIV treatment settings [5].
1.2. Research Questions. The research questions were
Is there a relationship between engagement with
care, substance use behaviors, and adherence to
therapy in HIV disease? Are there differences in
adherence related to health care providers (nurse,
advanced practice nurse/nurse practitioner, or
physician) or by site?
1.3. Purpose of the Study. As part of a larger randomized
controlled study conducted by an international HIV/AIDS
network on self-care for symptoms in HIV disease, the
purpose of the present study was to examine the participants’
perception of engagement with care, self-reported substance
use, and adherence to therapy. The parent study was a ran-
domized controlled trial of an HIV symptom management
manual and its effectiveness in addressing symptoms in HIV
disease. The prevalence of substance use behaviors including
excessive alcohol use, illicit drug use, and cigarette smoking
were examined as well as quality of life in HIV disease.
Although the larger study was a randomized controlled
trial of the use of a symptom management manual, the
present study reports on the descriptive, cross-sectional data
regarding engagement with care, adherence to therapy, and
substance use behaviors. SPSS PC version 16.0 was used to
analyze and categorize the study data. Quantitative methods
were used to analyze and summarize symptom data related to
unhealthy behaviors.
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2. Materials and Methods
This is a secondary analysis of data from a randomized
controlled trial to examine engagement with care, adherence,
and unhealthy self-care behaviors in a sample of persons
with HIV/AIDS. Data were collected in 14 sites in Africa
(Nairobi, Kenya, and Pretoria, South Africa), Puerto Rico,
and the United States (Boston, Chicago, Philadelphia, Salt
Lake City, San Diego, San Francisco, and Texas). The settings
included community-based organizations, university-based
AIDS clinics, private practices, public and for-profit hospitals,
residential and day care facilities, and home care services.
Institutional review board (IRB) approval was obtained at
each of the sites where data were collected as well as from the
UCSF International Nursing Research Network IRB.
2.1. Participants. The sample for this study included HIV-
infected individuals (𝑛 = 775) from the U.S. (Boston,
9.0%, Chicago 2.1%, Philadelphia, 13.8%, California 13.8%,
Texas 24.5%, and Salt Lake City 9.0%), Pretoria, South Africa
(6.2%), and Nairobi, Kenya (9.2%). Of the larger sample
of 775 participants, a majority of the respondents reported
substance use behaviors. Inclusion criteria for the study were
that participants had to be (a) at least 18 years of age, (b)
receiving HIV-related care at their respective facilities, (c)
able to provide informed consent, and (d) able to complete
the questionnaire independently or with the assistance of a
research assistant.
2.2. Measures
2.2.1. Demographic Survey. A 13-item self-report survey was
utilized to collect demographic information and illness back-
ground data for the study. Questions addressed personal
and environmental characteristics including age, gender,
years of education, adequacy of income, and whether they
had children among other variables. In addition, data on
biological/physiological factors, such as whether participants
had received an AIDS diagnosis or had any comorbidities,
were also collected.
2.3. Engagement with Health Care Provider (HCP). The
health care provider engagementwith care instrument (HCP)
is a 13-item scale where clients rate the nature of their
interactions with their health care providers on a four-
point scale with 1 = always true and 4 = never true. A
low score indicates greater provider engagement. The scale
was submitted to a principal components factor analysis
with varimax rotation. A one-factor solution emerged with
an eigenvalue of 8.6 and explaining 66.5% of the variance.
Cronbach’s alpha reliability estimate was 0.96 [7].
2.4. Revised ACTG Reasons for Nonadherence to Medications
(ACTGrev). The ACTG revised is a self-report measure of
reasons formissingmedications [13] that was revised through
a large randomized clinical control study on adherence.
In this study, clients were asked to respond to reasons
for missing medications using a 4-point Likert-type scale
ranging from never to often, with a higher score denoting
lesser adherence to their current medication regime. Factor
analysis was performed on Chesney and colleagues’ [13]
original 14 item instrument, producing 2 factors with a total
of nine items: pill taking problems (5 items) and forgetfulness
(4 items). These nine items constitute the revised scale.
Each factor or subscale can be summed separately and then
collectively to create the total score. Cronbach’s alphas for the
2 subscales and the total score ranged from 0.80 to 0.90.
2.5. Drug andAlcohol Use Scale (DAS). This 35-item scale was
derived from the Addiction Severity Index (ASI), which is
the most widely used standardized instrument in assessing
substance use [14]. The ASI is a semistructured interview
containing 161 questions in seven categories that assess
demographic information, medical status, employment and
education, family and social background, psychiatric status,
history of drug and alcohol use, and legal status. Test retest
reliability coefficients of 0.83 over a 2-day period have been
demonstrated with the whole tool. The 35-item drug and
alcohol scale was transformed from a semistructured format
to a self-report questionnaire for use in this study. This scale
inquires about lifetime use patterns and drug use episodes
specifically in the past 30 days. Administration time for the
drug and alcohol scale has been estimated at about 5minutes.
Level of substance use will be determined by the number of
times participants report using specific drugs in the past 30
days.
2.6. Data Analyses. Standard descriptive statistics were used
to describe the demographic characteristics, illness back-
ground, engagement with care, adherence to therapy, and
unhealthy behaviors for symptom management. The alpha
level for all statistics was set at 0.05 and SPSS (version 18.0)
was used for all data analyses. Means, standard deviations,
and 𝑡-tests for levels of engagement with care and unhealthy
behaviors were calculated. Significant differences between
engagement with care, adherence, and unhealthy behaviors
were examined.
3. Results
Demographic and illness background data are presented
in Table 1. The sample was composed of 59% (𝑛 = 455)
males, 38.5% (𝑛 = 296) females, and 2.2% (𝑛 = 17) who
self-identified as transgender. Ages ranged from 20 to 72
years (𝑀 = 42.8, SD 9.6 years). The largest racial groups
represented were African national and African American
(43.6%; 𝑛 = 335), Hispanic/Latino (27.8%; 𝑛 = 214), and
White/Anglo (21.2%; 𝑛 = 163). Most of the participants
had at least a high school education (70.9%; 𝑛 = 544)
although 78.2% (𝑛 = 604) indicated that their income was,
at best, barely adequate. Forty-two percent (𝑛 = 322) of
the participants had an AIDS diagnosis. The mean years of
known HIV-positive diagnosis was 9.1 years and the majority
of participants were currently taking antiretroviral medica-
tions (70.4%; 𝑛 = 537) and had been taking antiretroviral
medications for a mean number of 6.7 years. Their most
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Table 1: Sample demographics.
Gender
Male 455 59.2%
Female 296 38.5%
Transgender 17 2.2%
Age 42.8 years SD = 9.6 (range 20–72)
Race
Asian/Pacific Islander 11 1.4%
African national and American/black 335 43.6%
Hispanic/Latino 214 27.8%
Native American Indian 8 1.0%
White/Anglo (non-Hispanic) 163 21.2%
Other 37 4.8%
Highest education
Grade school 223 29.1%
High school 318 41.5%
Technical/vocational school 143 18.6%
College 59 7.7%
Master’s 20 2.6%
Doctorate 4 0.5%
# Children at home
0 139 37.9%
1 81 22.1%
2 80 21.8%
3 31 8.4%
>4 36 9.8%
Data Collection Sites
USA (10)
California (3) 107 13.8%
Texas (3) 190 24.5%
Massachusetts (1) 69 9.0%
Utah (1) 69 9.0%
Illinois (1) 16 2.0%
Pennsylvania (1) 107 13.8%
Africa (2)
South Africa (1) 48 6.2%
Kenya (1) 71 9.2%
Puerto Rico (2)
San Juan (1) 70 9.0%
Vega Baja (1) 28 3.6%
AIDS diagnosis
Yes 322 42.0%
No 408 53.2%
Don’t know 37 4.8%
Taking HIV Meds now
Yes 537 70.4%
No 226 29.6%
Other Medical Conditions
Yes 470 62.7%
No 280 37.3%
Years HIV Positive 9.1 years SD ± 6.6 (Range: 0–26)
Recent CD4 Count (if known) 407 SD ± 268 (Range: 0–1200)
Viral Load “Undetectable” 251 33.4%
Viral Load (Greater than 50 copies/mL) (𝑛 = 146) 50368 SD ± 135000 (Range: 50–750000)
Years on ARVMedications 6.7 years SD ± 5.2 (Range: 0–20)
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recent CD4 counts ranged from 0 to 1200 with a mean CD4
count of 407; 62.7% (𝑛 = 470) reported that they had other
comorbid medical conditions in addition to HIV/AIDS.
Several symptoms were significantly associated with
unhealthy substance use behaviors. In particular, fatigue and
emotional stress were correlated with all four substance use
behaviors (heavy alcohol use, illicit drug use, marijuana, and
tobacco). Of note is that nearly half of the sample (45.8%; 𝑛 =
355) reported tobacco use and nearly 15% reportedmarijuana
use (𝑛 = 111, 14.3%). Illicit drug use was self-reported by
2.6% of the sample (𝑛 = 98) and heavy alcohol use by 8.5%
(𝑛 = 66).
Figure 1 displays the baseline engagementwith care scores
by health care provider, site, and provider/site. Respondents
indicated that mean values on health care provider responses
were not significantly different for those whose care was
offered by physicians or those who had nurse providers
(physician care𝑀 = 18.4; nurse care𝑀 = 18.5). There were
also no significant differences in engagement with care by
site. It is of note that the engagement with care data was not
collected for this analysis in Kenya and thus analyses from
countries of Africa are limited. In some sites, respondents
indicated greater engagement with care when cared for by a
physician including. Participants in Boston and South Africa
had greater engagement with care reported by those who
received care from nurse; however, none of the engagement
with care scores were significantly different.
In Figure 2, baseline engagement with care and substance
use are displayed. The lowest scores of engagement with care
were for those who used hallucinogens (𝑀 = 23.6) followed
by cocaine users (𝑀 = 21.1). It is interesting to note that
for those who used heroin, the mean engagement with care
scores were low at 17.1. The lowest engagement with care
score was for those using barbiturate medications. However
none of the engagement with care scores were significantly
different based on self-report of specific illicit drugs used by
participants.The highest adherence scores and lowest reports
of substance use were in South Africa. Not surprisingly, mean
engagement with care scores were the highest in those who
did not report any drug use. Regarding adherence to therapy,
respondents in Puerto Rico had the poorest adherence to
therapy. For thosewhohad anurse provider, the highestmean
scores of adherence were in South Africa (0.111; 𝑛 = 9),
Philadelphia (5.35; 𝑛 = 17), and Boston (6.5; 𝑛 = 2). The
lowest mean scores of adherence were Puerto Rico (11.1; 𝑛 =
4), Texas (11.1; 𝑛 = 14), and San Diego (8.25; 𝑛 = 4).
It is of note that Wilcoxon 𝑡-tests indicated that symptom
burden was significantly higher for those who reported use
versus nonuse of alcohol (𝑃 < 0.001), tobacco (𝑃 < 0.001),
illicit drugs (𝑃 < 0.0001), and marijuana (𝑃 < 0.004).
Mean symptom burden for substance users for alcohol was
9.0, while nonusers reported a symptom burden of 6.6 (𝑃 <
0.001). For illicit drugs, mean symptom burden for users was
9.1, while nonusers reported a mean symptom burden score
of 6.5 (𝑃 < 0.0001). Marijuana users reported a symptom
burden of 8.3 and nonusers had a mean score of 6.5 (𝑃 <
0.004); tobacco users reported amean symptomburden score
of 7.6 and nonusers had a score of 6.1 (𝑃 < 0.001).
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Figure 1: Baseline engagement with care (by health care Provider,
site, and provider/site). Engagement with care is scaled such that
lower scores denote better engagement.
4. Discussion
In this study, substance use was associated with significantly
lower scores of engagement with care and linked with
poorer adherence to therapy. These results are important
in addressing HIV care and providing support for patients
across the trajectory of HIV disease. Although the sample
was primarily male, the HIV epidemic increasingly affects
female populations—particularly in the participants in South
Africa. Symptoms that were most associated with unhealthy
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Figure 2: Baseline engagement with care vis-a-vis substance use
within the past 30 days. Engagement with care is scaled such that
lower scores denote better engagement.
substance use behaviors were fatigue and emotional stress.
Both were significantly correlated with all four substance use
behaviors (heavy alcohol use, illicit drug use, marijuana, and
tobacco). Tobacco use was self-reported by nearly half of
the sample; thus education about the deleterious effects of
these substances is critical for nurses and other health care
providers. Many participants may also have become infected
due to injection drug use, so assessment of continuing sub-
stance use by health care providers is critical. Drug addiction
is universal; however, the factors leading to substance abuse
are complex across cultures and communities. In our study,
we found no significant differences in our analyses for US and
non-US participants living with HIV on types of substance,
demographics, education, or engagement with care variables.
Baseline engagement with care was not significantly
different depending upon providerswhether the providerwas
a nurse, advanced practice nurse, or physician providing care
inmost sites. It may be that HIV providers are a unique group
in their commitment to their patients and HIV care. This
may suggest that, even with complex patients including those
who use substances, HIV providers have greater empathy, are
attentive to the stigmatizing nature of the disease, and are
committed to quality care and accessibility.
Symptom burden was significantly higher for those who
reported use versus nonuse of alcohol, tobacco, illicit drugs,
and marijuana. This finding is important to discuss with
the patients living with HIV/AIDS. Many are likely using
substances to alleviate symptoms and, yet, may have a greater
number of symptoms as a result of substance use.
4.1. Recommendations for Future Research. These results offer
important contributions to the care of those living with HIV
and the importance of the relationship with the health care
provider. It is essential that health care providers practicing
in HIV settings incorporate assessment of substance use at
each health care visit. Interventions specifically tailored for
those with a history of substance use must also be utilized
for this population. In particular, HIV disease may have
occurred due to substance use and injection drugs. It is
important that assessment of ongoing substance use be a
key intervention at each visit with a provider. Evaluation of
educational interventions by providers should be conducted
at each HIV visit.
Future research should examine the HIV provider role
in assessment of substance use in those living with HIV
as well as substance use education. In addition, nurses and
physicians should actively engage in the comprehensive plan
of care as well as addressing the potential negative effects of
substance use for those with HIV/AIDS. As individuals live
longer with HIV disease as a chronic illness, other comorbid
conditions frequently arise (diabetes and heart disease) and
substance use may also add a complex dimension to their
care. Further research is likely to uncover additional interven-
tions that could support improved care of those with active
and past substance users in leading healthy lifestyles with
HIV disease.
Conflict of Interests
The authors report no conflict of interests regarding this
research.
Acknowledgments
This project was supported in part by the National Institutes
of Health (NIH): NIHUL1 RR024131, NIHT32NR007081,
NIH KL2RR024990, NIH R15NR011130, International Pilot
Award, University of Washington Center for AIDS Research,
University of Washington, School of Nursing, University
of British Columbia School of Nursing Helen Shore Fund,
DukeUniversity School ofNursingOffice of ResearchAffairs,
MGH Institute of Health Professions, Rutgers College of
Nursing, City University of New York, Irwin Belk Distin-
guished Professorship Fund, University of North Carolina
Wilmington, and Texas A&M University—Corpus Christi,
College of Nursing and Health Sciences. The contents of this
paper are solely the responsibility of the authors and do not
necessarily represent the official views of theNIHor any other
funders.
References
[1] T. E. Flickinger, S. Saha, R. D. Moore, andM. C. Beach, “Higher
quality communication and relationships are associated with
improved patient engagement in HIV care,” Journal of Acquired
Immune Deficiency Syndroms, vol. 63, no. 3, pp. 362–366, 2013.
[2] J. H. Samet, A. Y. Walley, and C. Bridden, “Illicit drugs, alcohol,
and addiction in human immunodeficiency virus,” Panminerva
Medica, vol. 49, no. 2, pp. 67–77, 2007.
[3] S. C. Kalichman, L. Simbayi, S. Jooste, R. Vermaak, andD. Cain,
“Sensation seeking and alcohol use predict HIV transmission
risks: prospective study of sexually transmitted infection clinic
patients, Cape Town, South Africa,”Addictive Behaviors, vol. 33,
no. 12, pp. 1630–1633, 2008.
[4] C. E. Golin, H. Liu, R. D. Hays et al., “A prospective study of pre-
dictors of adherence to combination antiretroviral medication,”
AIDS Research and Treatment 7
Journal of General Internal Medicine, vol. 17, no. 10, pp. 756–765,
2002.
[5] L. R. Metsch, M. Pereyra, G. Colfax et al., “HIV-positive
patients’ discussion of alcohol use with their HIV primary care
providers,” Drug and Alcohol Dependence, vol. 95, no. 1-2, pp.
37–44, 2008.
[6] K. J. Horvath, A. W. Carrico, J. Simoni, E. W. Boyer, K. R.
Amico, and A. E. Petroll, “Engagement in HIV medical care
and technology use among stimulant-using and non-stimulant-
using men who have sex with men,” AIDS Research and
Treatment, vol. 2013, Article ID 121352, 11 pages, 2013.
[7] S. Bakken, W. L. Holzemer, M.-A. Brown et al., “Relationships
between perception of engagement with health care provider
and demographic characteristics, health status, and adherence
to therapeutic regimen in persons with HIV/AIDS,” AIDS
Patient Care and STDs, vol. 14, no. 4, pp. 189–197, 2000.
[8] K. A. Christopoulos, A. D. Massey, A. M. Lopez et al., “Taking a
half day at a time: patient perspectives and theHIV engagement
in care continuum,” AIDS Patient Care and STDs, vol. 27, no. 4,
pp. 223–230, 2013.
[9] J. C. Dombrowski, M. M. Kitahata, S. E. van Rompaey et al.,
“High levels of antiretroviral use and viral suppression among
persons in HIV care in the United States, 2010,” Journal of
Acquired Immune Deficiency Syndromes, vol. 63, no. 3, pp. 299–
306, 2013.
[10] S. M. Bankoff, M. B. McCullough, and D. W. Pantalone,
“Patient-provider relationship predicts mental and physical
health indicators forHIV-positivemenwho have sexwithmen,”
Journal of Health Psychology, vol. 18, no. 6, pp. 762–772, 2013.
[11] K. C. Rao, M. Enriquez, T. C. Gantt et al., “Nonengagement
in HIV care: a descriptive and qualitative study in hospitalized
patients and community-based analysis,” Journal of the Interna-
tional Association of Providers of AIDS Care, vol. 12, no. 3, pp.
178–184, 2013.
[12] M. J. Mugavero, W. E. Norton, and M. S. Saag, “Health care
system and policy factors influencing engagement in HIV
medical care: piecing together the fragments of a fractured
health care delivery system,” Clinical Infectious Diseases, vol. 52,
supplement 2, pp. S238–S246, 2011.
[13] M. A. Chesney, J. R. Ickovics, D. B. Chambers et al., “Self-
reported adherence to antiretroviral medications among par-
ticipants in HIV clinical trials: the AACTG adherenceinstru-
ments,” AIDS Care: Psychological and Socio-Medical Aspects of
AIDS/HIV, vol. 12, no. 3, pp. 255–266, 2000.
[14] A. T. McLellan, H. Kushner, D. Metzger et al., “The fifth edition
of the addiction severity index,” Journal of Substance Abuse
Treatment, vol. 9, no. 3, pp. 199–213, 1992.
